Knightsbridge Asset Management, LLC
- SEC CIK
- 0001332811
- Latest filing
- Aug 13, 2026
CTMX holding history
CytomX Therapeutics, Inc. in every 13F filed by Knightsbridge Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CTMX overviewAll 13F holders of CTMXFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q2 2022